Liven Pharma Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Dec '25 Dec 12, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Market Capitalization	5,020	6,042	110	185	152	303	Upgrade
Market Cap Growth	614.96%	5370.54%	-40.46%	21.91%	-49.80%	127.48%	Upgrade
Enterprise Value	5,047	6,080	349	423	387	535	Upgrade
PE Ratio	-	-	2.65	-	-	-	Upgrade
PS Ratio	39.45	47.47	0.45	-	-	-	Upgrade
PB Ratio	7.92	9.53	0.15	-1.51	-1.38	-3.16	Upgrade
P/TBV Ratio	8.03	9.66	0.15	-	-	-	Upgrade
P/FCF Ratio	-	-	8.00	-	-	-	Upgrade
P/OCF Ratio	-	-	8.00	-	-	-	Upgrade
EV/Sales Ratio	39.66	47.77	1.42	-	-	-	Upgrade
EV/EBITDA Ratio	-	-	5.37	-	-	-	Upgrade
EV/EBIT Ratio	-	-	8.35	-	-	-	Upgrade
EV/FCF Ratio	-205.50	-	25.26	-	-	-	Upgrade
Debt / Equity Ratio	0.06	0.06	0.21	-1.94	-2.13	-2.43	Upgrade
Debt / EBITDA Ratio	-	-	2.35	-	-	-	Upgrade
Debt / FCF Ratio	-	-	11.37	-	-	-	Upgrade
Asset Turnover	0.14	0.14	0.46	-	-	-	Upgrade
Inventory Turnover	0.90	0.90	-	-	-	-	Upgrade
Quick Ratio	0.19	0.19	0.71	0	0	0	Upgrade
Current Ratio	1.64	1.64	1.48	0	0	0.00	Upgrade
Return on Equity (ROE)	-84.49%	-84.49%	13.31%	-	-	-	Upgrade
Return on Assets (ROA)	-35.12%	-35.12%	4.93%	-6.89%	-7.20%	-6.80%	Upgrade
Return on Capital (ROIC)	-39.02%	-39.02%	5.11%	-7.93%	-8.35%	-8.08%	Upgrade
Return on Capital Employed (ROCE)	-67.10%	-67.10%	5.60%	14.20%	19.10%	24.50%	Upgrade
Earnings Yield	-11.64%	-9.67%	37.80%	-6.65%	-9.39%	-4.83%	Upgrade
FCF Yield	-0.49%	-0.41%	12.50%	-1.22%	-1.49%	-2.24%	Upgrade
Buyback Yield / Dilution	-174375.69%	-174375.69%	99.67%	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.